JNJ

270.4701.25%
JJ

Joseph James Wolk

Executive VP & CFO

Mr. Joseph James Wolk, also known as Joe, C.P.A., is Executive Vice President and Chief Financial Officer at Johnson & Johnson since July 1, 2018. Mr. Wolk is Director of The Prudential Insurance Company of America from October 2025. He is Independent Director at Prudential Financial, Inc. since September 30, 2025. He served as Director since May 03, 2023 till 2024 at Kenvue Inc. He was Vice President of Investor Relations at Johnson & Johnson since August 1, 2016. Mr. Wolk served as Vice President of Group Finance for the Pharmaceuticals Group at Johnson & Johnson. He is also the executive sponsor of Johnson & Johnson’s Impact Venture Fund and Veterans Leadership Council and champions Johnson & Johnson’s Finance Leadership Development Program. He held other finance leadership positions at Johnson & Johnson as Vice President of Finance for the Medical Devices Global Supply Chain and as Chief Financial Officer of the North America Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc., as well as U.S. Pricing Strategy and Compliance. Mr. Wolk joined Johnson & Johnson in 1998 as a Finance Manager in the Ortho McNeil Pharmaceutical organization. Prior to Johnson & Johnson, he held multiple positions of increasing responsibility at Ametek, Inc. Mr. Wolk serves on the Haub School of Business Board of Visitors. He is a member of the Stanford Medicine Board of Fellows, the CNBC Global CFO Council and the Wall Street Journal CFO Network. He serves on the St. Joseph’s University Board of Trustees. He holds a Bachelor of Science degree in Finance from St. Joseph's University. Mr. Wolk also holds a Juris Doctor degree from Temple University School of Law and is a Certified Public Accountant.

Positions